Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
58.36
+1.45 (2.55%)
At close: Mar 27, 2026
SHE:300049 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 649.74 | 566.83 | 509.59 | 479.21 | 472.72 |
Trading Asset Securities | 83.62 | 157.5 | 94.11 | 136.2 | 145.8 |
Cash & Short-Term Investments | 733.36 | 724.33 | 603.7 | 615.41 | 618.52 |
Cash Growth | 1.25% | 19.98% | -1.90% | -0.50% | 19.89% |
Accounts Receivable | 475.61 | 555.37 | 457.51 | 456.49 | 365.55 |
Other Receivables | 14.49 | 36.31 | 31.09 | 25.01 | 19.91 |
Receivables | 490.1 | 591.69 | 488.59 | 481.49 | 385.46 |
Inventory | 148.97 | 140.84 | 100.37 | 97.4 | 100.49 |
Prepaid Expenses | - | 23.1 | 19.43 | 11.43 | 0.22 |
Other Current Assets | 172.09 | 43.74 | 42.75 | 24.7 | 38.28 |
Total Current Assets | 1,545 | 1,524 | 1,255 | 1,230 | 1,143 |
Property, Plant & Equipment | 579.59 | 492.18 | 403.24 | 385.87 | 387.44 |
Long-Term Investments | 240.51 | 139.85 | 222.85 | 237.19 | 348.23 |
Goodwill | 179.5 | 205.09 | 135.89 | 135.89 | 135.89 |
Other Intangible Assets | 583.23 | 558.15 | 442.02 | 417.96 | 416.78 |
Long-Term Deferred Tax Assets | 70.16 | 57.33 | 48.05 | 45.06 | 35.82 |
Long-Term Deferred Charges | 6.28 | 5.3 | 6.49 | 13.85 | 14.95 |
Other Long-Term Assets | 235.13 | 77.3 | 134.09 | 56.82 | 42.56 |
Total Assets | 3,439 | 3,059 | 2,647 | 2,523 | 2,525 |
Accounts Payable | 128.75 | 115 | 80.09 | 72.41 | 61.12 |
Accrued Expenses | 118.3 | 120.51 | 113.93 | 107.85 | 105.53 |
Short-Term Debt | - | - | - | 1.16 | 40 |
Current Portion of Long-Term Debt | 106.55 | - | - | - | - |
Current Portion of Leases | - | 21.18 | 14.44 | 12.68 | 14.23 |
Current Income Taxes Payable | 37.5 | 32.4 | 18.87 | 13.33 | 37.53 |
Current Unearned Revenue | 8.49 | 12.83 | 6.71 | 1.87 | 4.3 |
Other Current Liabilities | 82.66 | 67.64 | 64.33 | 27.52 | 10.54 |
Total Current Liabilities | 482.25 | 369.55 | 298.37 | 236.81 | 273.25 |
Long-Term Leases | 69.43 | 55.24 | 44.9 | 41.83 | 54.13 |
Long-Term Unearned Revenue | 373.9 | 429.92 | 403.92 | 401.98 | 388.21 |
Long-Term Deferred Tax Liabilities | 9.24 | 6.38 | 2.59 | 2.34 | - |
Other Long-Term Liabilities | 32.52 | 69.89 | 50.31 | 14.3 | 3.37 |
Total Liabilities | 967.33 | 930.99 | 800.09 | 697.25 | 718.97 |
Common Stock | 264.98 | 266.36 | 263.05 | 263.05 | 263.05 |
Additional Paid-In Capital | 818.37 | 839.82 | 656.94 | 672.17 | 639.87 |
Retained Earnings | 1,003 | 848.99 | 740.04 | 740.1 | 642.22 |
Treasury Stock | -34.78 | -59.75 | - | - | - |
Comprehensive Income & Other | -73.31 | -147.73 | -112.71 | -129.91 | -25.58 |
Total Common Equity | 1,978 | 1,748 | 1,547 | 1,545 | 1,520 |
Minority Interest | 493.26 | 380.23 | 300.06 | 280.43 | 286.11 |
Shareholders' Equity | 2,472 | 2,128 | 1,847 | 1,826 | 1,806 |
Total Liabilities & Equity | 3,439 | 3,059 | 2,647 | 2,523 | 2,525 |
Total Debt | 175.98 | 76.42 | 59.34 | 55.68 | 108.36 |
Net Cash (Debt) | 557.38 | 647.91 | 544.36 | 559.73 | 510.17 |
Net Cash Growth | -13.97% | 19.02% | -2.75% | 9.72% | 31.30% |
Net Cash Per Share | 2.10 | 2.45 | 2.07 | 2.13 | 1.96 |
Filing Date Shares Outstanding | 273.46 | 259.37 | 263.05 | 263.05 | 263.05 |
Total Common Shares Outstanding | 273.46 | 259.37 | 263.05 | 263.05 | 263.05 |
Working Capital | 1,062 | 1,154 | 956.47 | 993.63 | 869.73 |
Book Value Per Share | 7.23 | 6.74 | 5.88 | 5.87 | 5.78 |
Tangible Book Value | 1,216 | 984.44 | 969.42 | 991.56 | 966.9 |
Tangible Book Value Per Share | 4.45 | 3.80 | 3.69 | 3.77 | 3.68 |
Buildings | - | 78.37 | 126.34 | 126.33 | 126.45 |
Machinery | - | 224.68 | 191.51 | 163.59 | 141.96 |
Construction In Progress | - | 294.17 | 191.91 | 186.68 | 182.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.